FOXA1 and nasopharyngeal carcinoma: Utilizing a larger cohort of 175 NPC and 61 non-cancerous nasopharyngeal epithelia cases, we demonstrated that loss of FOXA1 was significantly associated with larger tumor size, lymphatic metastasis, distant metastasis, advanced clinical stages, and the undifferentiated histological subtype.